Treatment Trials

4 Clinical Trials for Various Conditions

Focus your search

      COMPLETED
      Angiomax in Patients With HIT/HITTS Type II Undergoing CPB
      Description

      The purpose of this study is to demonstrate that in patients with heparin-induced thrombocytopenia (HIT)/heparin-induced thrombocytopenia and thrombosis syndrome (HITTS) Type II undergoing cardiac surgery on cardiopulmonary bypass (CPB), Angiomax is a safe and effective anticoagulant.

      Conditions
      Cardiovascular DiseaseCoronary Artery Bypass Surgery
      Talk to us
      WITHDRAWN
      Bivalirudin PCI Registry in Heparin Induced Thrombocytopenia/Heparin Induced Thrombocytopenia and Thrombosis Syndrome (HIT/HITTS) Patients
      Description

      To monitor the frequency of the development of thrombocytopenia in patients with Heparin Induced Thrombocytopenia/Heparin Induced Thrombocytopenia and Thrombosis Syndrome receiving bivalirudin during Percutaneous Coronary Intervention

      Conditions
      Heparin-Induced ThrombocytopeniaHeparin-induced Thrombocytopenia and Thrombosis Syndrome
      Talk to us
      COMPLETED
      Angiomax in Patients With HIT/HITTS Type II Undergoing Off-Pump Coronary Artery Bypass Grafting (CABG) (CHOOSE)
      Description

      The purpose of this study is to examine the safety and efficacy of Angiomax as an anticoagulation in patients with heparin-induced thrombocytopenia (HIT)/heparin-induced thrombocytopenia with thrombosis syndrome (HITTS) undergoing off-pump coronary artery bypass (OPCAB) surgery.

      Conditions
      ThrombocytopeniaThrombosisCardiac DiseaseCoronary Artery Bypass Surgery
      Talk to us
      TERMINATED
      A Comparative Sudy Comparing Argatroban® IV vs Desirudin SC for Suspected HIT With or Without Thrombosis Syndrome
      Description

      Compare Clinical Success and Costs in two Arms

      Conditions
      Suspected Heparin-Induced Thrombocytopenia
      Talk to us